Beschreibung
CD23 is a type 2 transmembrane C-type lectin that binds IgE, CD21, CD11b and CD11c. It is expressed on a variety of hematopoietic cells and functions in allergic immune responses. Recombinant human sCD23 is a 19.2 kDa non-glycosylated protein containing 172 amino-acid residues.
Product Properties
|
Alternative Names |
FCER2 |
|
Species |
Human |
|
Expression Sequence |
Met1-Ser321 |
|
Accession |
P06734 |
|
Tag |
No Tag |
|
Expression System |
E.coli |
|
Molecular Weight |
Approximately 19.2 kDa. |
|
Purity |
> 95% as determined by SDS-PAGE and HPLC. |
|
Endotoxin |
< 0.1 EU per µg by the LAL method. |
|
Formulation |
Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4. |
|
Appearance |
Lyophilized Powder |
|
Biological Activity |
The ED50determined by its ability to induce TNF-alpha production by human PBMCs. Fully biologically active when compared to standard. |
|
Reconstitution Method |
Before opening the lid, centrifuge to bring the contents to the bottom. Reconstitute with sterile distilled water or PBS and reconstitute to a concentration of 0.1-1.0 mg/mL. It can be further diluted according to subsequent experiments. For long-term storage, it is recommended to add carrier protein (0.1% BSA) to the dilution buffer. Aliquot into the amount for one experiment and freeze at -80℃ to avoid repeated freezing and thawing. |
Features
High purity, high activity, low endotoxin, high batch-to-batch consistency
Storage
Store at -25 ~ -15℃, valid for 1 year after receipt. After reconstitution, store at -85 ~ -65℃ under sterile conditions, valid for 3 months.
Zahlung und Sicherheit
Ihre Zahlungsinformationen werden sicher verarbeitet. Wir speichern weder Kreditkartendaten noch Zugriff auf Ihre Kreditkarteninformationen.
Anfrage
Sie können auch mögen
FAQ
Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von
Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.